FDA Person
FDAHamet M. Toure
View detailed information about Hamet M. Toure, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 16 inspections of 16 companies, 2023–2026.
Inspections (16)
Documents (8)
- EIR · UCB Pharma S.A. · April 21, 2023
- 483 · LSNE Madison LLC · October 11, 2024
- 483 · AbbVie Ireland NL. B.V. · September 10, 2024
- 483 · Intas Pharmaceuticals Ltd. · February 14, 2025
- 483 · Catalent Belgium SA · July 12, 2024
- 483 · Chugai Pharma Manufacturing Co. Ltd. (CPMC) · March 29, 2024
- 483 · Regeneron Pharmaceuticals, Inc. · January 16, 2026
- 483 · Lupin Limited (Biotech Division) · September 19, 2025
Frequently inspected with (10)
Madushini N. Dharmasena
3 shared
Cassandra L. Abellard
investigator
2 shared
Alice S. Tsao
Consumer Safety Officer at FDA
1 shared
Andrea Franco
Pharmaceutical Scientist
1 shared
Ayyappan Rathakrishnan
1 shared
Bingchen Du
1 shared
Caryn M. Mcnab
1 shared
Doan N. Singh
1 shared
Jiangsong Jiang
1 shared
Jill J. Tillman
1 shared
Person Information
Name
Hamet M. Toure
Title
other
Role
COMPANY REP
ID: 9f3726f3-b118-4247-9793-738557aa1ee8
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.